Taylor Wessing is the exclusive European legal sponsor of the 15th Annual BioPartnering Europe Conference
Taylor Wessing is the exclusive European legal sponsor of the 15th Annual BioPartnering Europe (BPE) Conference, on 7-9 October 2007. The firm's Life Sciences & Healthcare Group will be hosting two workshops and chairing a leadership session at the event.
Dr Malcolm Bates will chair a leadership session discussion. Against a background of the biologicals sector's recent move into the mainstream, with big pharma seeking to establish themselves in the sector and a new wave of companies seeking to emulate the success of the early biotech pioneers, the discussion will consider the partnering of biologicals from the perspective of big pharma, big biotech and the R&D stage company, including current issues and trends.
Dr Malcolm Bates will also be chairing a workshop alongside partner Daniel Pavin, which will review industry trends and how those trends are affecting the terms of agreements commonly used in life sciences, looking more specifically at the effects that geographic expansion can have on how template agreements work, what evolving CRO business models mean for outsourced research agreements, and the risks associated with virtualisation rather than doing things in-house.
Daniel Pavin comments:
"Deal terms between pharma and biotech have been evolving, in many instances in biotech's favour, as pharma reacts to pressures such as dwindling product pipelines. Business models throughout the life sciences value chain are also evolving. Emerging markets, for example, are increasingly becoming targets for partnering, outsourcing and distribution. Life sciences companies should therefore be thinking about whether the contracts they use have kept pace and, if those contracts are to be used in new markets, whether they need adapting to make sure that they still work effectively."
In addition, UK and German partners Simon Walker and Dr Christian Traichel will host a workshop to highlight potential pitfalls and best practice tips for those growing their business by fundraising or partnering, to ensure a smooth exit.
For more information or to speak to a member of Taylor Wessing's Life Sciences & Healthcare Group, please contact Sarah le Cheminantat Taylor Wessing:
Tel: +44 (0)20 7300 4930
Email: s.lecheminant@taylorwessing.com
Notes to editors
Taylor Wessing is one of three platinum sponsors of the 15th Annual BioPartnering Europe, along with AstraZeneca and Procter & Gamble Pharmaceuticals. Other sponsors include Deloitte, Wyeth, Pfizer, Merck and Novartis.
Further information about BioPartnering Europe may be found at www.techvision.com/bpe.
Taylor Wessing's Life Sciences & Healthcare Group is top-ranked in the 2007 edition of UK Legal 500, based on its "high-end technology and life sciences work, for which it is among the best in Europe". The Group is also top-ranked in the PLC Cross-border Life Sciences Handbook 2006/07 for both intellectual property work and partnering work.
The Group provides a top quality, multi-disciplinary service and combines Taylor Wessing’s top-rated intellectual property and venture capital lawyers with specialists from our highly acclaimed international corporate, corporate finance, employment and real estate practices. We advise life sciences and healthcare businesses, those who fund them and those who work for them.
Taylor Wessing LLP is a leading law firm providing legal support for commercial organisations doing business in Europe. Based in Belgium, France, Germany and the UK, Taylor Wessing provides the full range of legal services to major corporations and growing enterprises. Taylor Wessing boasts a strong reputation in the corporate, finance and real estate sectors alongside in-depth experience across the full range of legal services including intellectual property and technology, tax, litigation & dispute resolution, employment & pensions and private client.
